The goal of this implementation trial is to evaluate the clinical outcomes associated with usual physiotherapy care compared to individualized physiotherapy in accordance with the Specific Treatment of Problems of the Spine (STOPS) approach in patients with chronic low back pain (CLBP). The main questions it aims to answer are: * Is the STOPS approach more effective than usual care physiotherapy among patients with CLBP? * Is STOPS physiotherapy cost-effective compared to usual physiotherapy care for patients with CLBP. * Does STOPS training improve the quality of care among Bangladeshi physiotherapists?
The goal of this implementation trial is to evaluate the clinical outcomes associated with usual physiotherapy care compared to individualized physiotherapy in accordance with the Specific Treatment of Problems of the Spine (STOPS) approach in patients with chronic low back pain (CLBP). The main questions it aims to answer are: * Is the STOPS approach more effective than usual care physiotherapy among patients with CLBP? * Is STOPS physiotherapy cost-effective compared to usual physiotherapy care for patients with CLBP. * Does STOPS training improve the quality of care among Bangladeshi physiotherapists? In phase I, patients with CLBP will be treated with usual physiotherapy care. In phase II, Bangladeshi physiotherapists will be provided with a STOPS training program by the Australian developers of STOPS. In phase III, the trained Bangladeshi physiotherapists will treat patients using the STOPS approach. Clinical patient outcomes will be evaluated in Phase 1 and Phase 3 (pre and post implementation). Physiotherapists' self-confidence and implementation behaviour will be evaluated before and after STOPS training. A qualitative study of physiotherapists' and patients' experiences will be conducted after the completion of the usual care (Phase I) and STOPS treatment programs (Phase III).
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
154
In Phase 1, physiotherapists will provide treatment for participants with chronic low back pain in accordance with their current standard physiotherapy practice. Physiotherapists will be free to choose the treatment approach they wish to.
In Phase 3, participants will receive individualized physiotherapy in accordance with the Specific Treatment of Problems of the Spine (STOPS) approach modified for chronic low back pain. Treatment will be individualized on the basis of biopsychosocial assessment findings including dominant pain type (nociceptive, neuropathic or nociplastic), pathoanatomical subgroups (if any), and other barriers to recovery (eg. inflammation, depression, anxiety, stress, catastrophising, pain self-efficacy, and unhelpful motor control strategies). Available treatment strategies will include individualized education/advice, exercise, manual therapy, activity modification/facilitation, goal setting, motor control optimisation, cognitive-behavioural strategies, inflammation management, pain management strategies, sleep management, work management, and relaxation approaches.
Uttara Adhunik Medical College Hospital
Dhaka, Uttara, Bangladesh
RECRUITINGActivity limitation
Oswestry Disability Questionnaire (ODI). Measured from 0-100% with lower scores meaning less disability.
Time frame: Primary endpoint will be 26 weeks post-enrolment.
Back Pain Intensity
0-10 numerical pain rating scale, average over the previous week. Lower scores indicate a better outcome.
Time frame: Primary endpoint will be 26 weeks post-enrolment.
Leg Pain Intensity
0-10 numerical pain rating scale, average over the previous week. Lower scores indicate a better outcome.
Time frame: Primary endpoint will be 26 weeks post-enrolment.
Work hours missed
Number of work/housework hours missed during the past 7 days (continuous scale from 0 to 50). Lower score indicated less hours missed (better outcome)
Time frame: 5, 10, and 26-weeks post enrolment
Work productivity
0-10 numerical rating scale of how much pain affected work productivity in the last 7 days. Score 0-10, with lower scores indicating less interference with work productivity.
Time frame: 5, 10, and 26-weeks post enrolment
Short-Form Örebro Musculoskeletal Pain Screening Questionnaire (ÖMPSQ-SF)
The total score ranges between 1 and 100, with higher scores indicating a worse outcome.
Time frame: 5, 10, and 26-weeks post enrolment
Health-related quality of life (EQ-5D-5L)
Utility scores will be calculated from the EuroQOL-5D-5L, with scores ranging from -0.148 to 0.949 (higher scores indicate better quality of life)
Time frame: 5, 10, and 26-weeks post enrolment
Depression, Anxiety and Stress Scales - DASS-21
The DASS-21 measures symptoms of stress, anxiety and depression, with a total composite score ranging from 0-63 with higher scores indicating more severe symptoms of distress.
Time frame: 5, 10, and 26-weeks post enrolment
Pain Self Efficacy
Pain Self Efficacy Questionnaire (PSEQ). A raw score is presented with a range from 0 - 60, where high scores indicate greater levels of confidence in dealing with pain (better outcome).
Time frame: 5, 10, and 26-weeks post enrolment
Pain Catastrophizing
Pain Catastrophizing Scale (PCS). The score ranges from 0 to 52. A higher score denotes more catastrophizing (worse outcome)
Time frame: 5, 10, and 26-weeks post enrolment
Sleep quality
Insomnia Severity Index (ISI-7). Score ranges from 0 to 28, with higher scores indicating worse sleep quality (worse outcome)
Time frame: 5, 10, and 26-weeks post enrolment
Central Sensitisation symptoms
Central Sensitisation Inventory (CSI-9). Score ranges from 0 to 36, with higher scores indicating more symptoms indicative of potential central sensitisation
Time frame: 5, 10, and 26-weeks post enrolment
Inflammatory symptoms
The 4-item clinical inflammation score will measure low back-related inflammatory symptoms. Scores range from 0 to 4, with higher scores indicating more inflammatory symptoms (worse outcome)
Time frame: 5, 10, and 26-weeks post enrolment
Treatment Credibility
Treatment credibility questionnaire. Scored 0-10. A higher score indicates greater confidence in the treatment (better outcome).
Time frame: 5, 10, and 26-weeks post enrolment
Healthcare utilization
A patient diary will be used to track healthcare service utilization, imaging, and medication. These are recorded descriptively.
Time frame: 5, 10, and 26-weeks post enrolment
Participant adherence with treatment
Participant adherence with treatment will be determined via a self-administered 0-10 rating scale, with higher scores indicating greater adherence with treatment (better outcome).
Time frame: 5, 10, and 26-weeks post enrolment
Global rating of change
Global change will be measured on a 7-point scale ranging from "very much worse" to "very much better". Scores range from 1-7, with a higher score indicating greater improvement.
Time frame: 5, 10, and 26-weeks post enrolment
Satisfaction with treatment
Participants will rate their satisfaction with physiotherapy treatment on a 5-point Likert scale, with ratings from "very satisfied" to "very dissatisfied".
Time frame: 5, 10, and 26-weeks post enrolment
Adverse events
Adverse effects events (harmful or unpleasant) will be recorded descriptively in the therapists clinical notes.
Time frame: 5, 10, and 26-weeks post enrolment
Qualitative interviews
Semi-structured interviews relating to the patient's experiences with the Usual care and STOPS physiotherapy will be conducted.
Time frame: 10 weeks post-enrolment
Pain severity
Brief Pain Inventory. Average of the four pain severity items, scores range from 0-10, lower scores indicate less pain severity.
Time frame: 5, 10, and 26-weeks post enrolment
Pain interference
Brief Pain Inventory. Average of the seven pain interference items, scores range from 0-10, lower scores indicate less pain interference.
Time frame: 5, 10, and 26-weeks post enrolment
Back Pain Intensity
0-10 numerical pain rating scale, average over the previous week. Lower scores indicate a better outcome.
Time frame: 5, 10 and 52-weeks post enrolment
Leg Pain Intensity
0-10 numerical pain rating scale, average over the previous week. Lower scores indicate a better outcome.
Time frame: 5, 10 and 52-weeks post enrolment
Activity limitation
Oswestry Disability Questionnaire (ODI). Measured from 0-100% with lower scores meaning less disability.
Time frame: 5, 10 and 52-weeks post enrolment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.